Despite the Affordable Care Act being labelled as bad for business, there is one industry segment that has definitely profited under the ACA – health insurers.

The states’ challenge to the ACA Medicaid expansion is motivated by the increasing costs the program will impose on state budgets. The challenge will still likely fail.

The increased use of legal narcotics has resulted in more overdose deaths and increased Medicare and Medicaid fraud.

Here is my FantasySCOTUS prediction on the question of the individual mandate’s severability in the Supreme Court’s case on the health care law. Part 5 of 5.

CMS has finally issued its proposed rule to require manufacturers of drugs, devices, biologicals, or medical supplies to report payments of $10 or more made to physicians or teaching hospitals.

Calls for the recusals of Justices Thomas and Kagan have been made since legal challenges to the PPACA began. It’s very unlikely that either will recuse, though.

Here is the second half of my FantasySCOTUS prediction on the question of the individual mandate’s constitutionality of the Supreme Court’s case on the health care law. Part 4 of 5.

Pfizer recently lost patent protection on its popular drug Lipitor. However, it is fighting to keep its market share regardless, an effort that will drive up healthcare costs.

Here is the first half of my FantasySCOTUS prediction on the question of the individual mandate’s constitutionality of the Supreme Court’s case on the health care law. Part 3 of 5.

In my last post, I discussed a few of the changes federal and state governments have made in their ongoing efforts to…